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A growing body of evidence implicates the mycobacterial cap-
sule, the outermost layer of the mycobacterial cell envelope, in
modulation of the host immune response and virulence of myco-
bacteria. Mycobacteria synthesize the dominant capsule compo-
nent, (134)-linked glucan, via three interconnected and poten-
tially redundant metabolic pathways. Here, we report the crystal
structure of the Mycobacterium smegmatis TreS:Pep2 complex,
containing trehalose synthase (TreS) and maltokinase (Pep2),
which converts trehalose to maltose 1-phosphate as part of the
TreS:Pep2–GlgE pathway. The structure, at 3.6 A˚ resolution,
revealed that a diamond-shaped TreS tetramer forms the core of
the complex and that pairs of Pep2 monomers bind to opposite
apices of the tetramer in a 4  4 configuration. However, for the
M. smegmatis orthologues, results from isothermal titration calo-
rimetry and analytical ultracentrifugation experiments indicated
that the prevalent stoichiometry in solution is 4 TreS  2 Pep2
protomers. The observed discrepancy between the crystallized
complexand thebehavior in the solution statemaybeexplainedby
the relatively weak affinity of Pep2 for TreS (Kd 3.5 M at mildly
acidic pH) and crystal packing favoring the 4 4 complex. Prox-
imity of the ATP-binding site in Pep2 to the complex interface
provides a rational basis for rate enhancement of Pep2 upon bind-
ing toTreS,but thecomplex structureappears to ruleout substrate
channelingbetween the active sites ofTreS andPep2.Our findings
provide a structural model for the trehalose synthase:maltokinase
complex inM. smegmatis that offers critical insights into capsule
assembly.
Through co-evolution with its host over several millennia,
Mycobacterium tuberculosis, the organism causing tuberculo-
sis (TB),5 has developed mechanisms to partially blunt the
human immune response. A key role in this finely tuned host–
pathogen interaction is played by various components of the
complex mycobacterial cell wall, notably lipoarabinomannan
and phosphatidylinositol-anchored mannan (1). Compared
with these immunomodulatory cell wall components, the myco-
bacterial capsule has received relatively little attention. Yet, in-
creasing evidence points to a role of the capsule in immune
modulation and virulence. For instance, destructionof the capsule
by sonication promotes phagocytosis ex vivo (2); capsular polysac-
charides bind with high selectivity to DC-SIGN, a key receptor of
the innate immune system on dendritic cells (3); deletion of the
glgA gene, which encodes a component of the “classical” pathway
of-glucan synthesis, perturbs persistence of bacilli in a mouse
infection model for TB (4); and phagocytosis of nonopsonized
bacilli by neutrophils appears to bemediated by capsular-glu-
can (5). Finally, double knockout mutants deleting ADP-glucose
pyrophosphorylase–encoding glgC and trehalose synthase–
encoding treS led to severe capsule-deficiency and significantly
reduced virulence of M. tuberculosis in a mouse infection model
(6), underscoring the significance of the capsule in TB infections.
How the capsule is synthesized and assembled is only par-
tially understood. The capsule material is predominantly made
of -glucan (80–90%), alongside other key components,
including arabinomannan (10–20%) and proteins of the ESX-1
secretion system (7). Capsular -glucan is a polymer of
(134)-linked glucose units with (136)-branching and thus
is structurally closely related to intracellular glycogen (8, 9). To
date, three mycobacterial pathways have been implicated in
-glucan (and/or glycogen) synthesis: the classical GlgC–GlgA
pathway (also present in many other bacteria), the Rv3032
pathway (which leads to methylglucose lipopolysaccharide
(10)), and the recently identified TreS-Pep2-GlgE (Fig. 1) (9, 11,
12). These pathways share either common nodes or are linked
by synthetic lethal interactions (9, 11, 13), conferring an
intriguing level of metabolic redundancy. Recent evidence has
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shown that simultaneous knockout of the classical pathway
(GlgC–GlgA) and the GlgE pathway by deleting glgC and treS
abolishes capsule formation and significantly reduces viru-
lence, whereas single knockouts of these two genes partially
preserve -glucan synthesis and have differential effects on
-glucan content in the capsule and the cytosol (6).
In a previous study, we had described the crystal structure of
trehalose synthase (TreS) ofM. tuberculosis (14), which consti-
tutes the entry point to the four-step GlgE pathway of -glucan
synthesis (Fig. 1). In the same study, we showed that TreS,
which interconverts trehalose andmaltose (15), forms a nonco-
valent complex in vitro and in vivowithmaltokinase (Pep2), the
second enzyme in the GlgE pathway. Pep2 catalyzes phosphate
transfer from ATP to maltose (16), yielding maltose 1-phos-
phate, which is subsequently polymerized by GlgE into
(134)-linked glucan (12). In a fourth reaction step, GlgB
introduces (136)-branching of (134)-linked glucan chains
(17). Contrary to GlgE or GlgB, neither TreS nor Pep2 are
essential enzymes in Mycobacterium smegmatis, although
transposon mutagenesis suggested the essentiality ofM. tuber-
culosis Pep2 (18). However, they have been shown to form syn-
thetic lethal interactions with glycosyltransferase Rv3032
(which synthesizes linear -glucan from UDP-glucose) and
thus appear to occupy an important metabolic node (11).
The TreS:Pep2 complex of M. tuberculosis contains a
tetramer of TreS and four copies of Pep2, with an overall mass
of 490 kDa (14). TreS and Pep2 canwork independently, but we
observed that when M. tuberculosis TreS is added to the
M. tuberculosis Pep2-catalyzed phosphorylation of maltose,
Pep2 activity increased markedly (14). This raised the question
bywhatmechanismTreS is able to affect the catalytic activity of
Pep2 and/or whether substrate channeling may be part of the
TreS:Pep2 interaction. To help address these questions, we
undertook the crystallization of the TreS:Pep2 complex. Crys-
tals of theM. tuberculosis complex failed to provide useful dif-
fraction patterns, whereas diffraction data could be obtained
with crystals of the orthologues fromM. smegmatis, diffracting
to a resolution of 3.6 Å.
Results
X-ray crystal structure of theM. smegmatis TreS:Pep2 complex
The complex ofM. smegmatis (Msm) TreS:Pep2 crystallized
readily, but crystals of appropriate quality only grew over a nar-
row pH range (pH 6.7 to 7.0). The structure was phased by
molecular replacement and refined to a resolution of 3.6 Å (Fig.
2 and Table S1). Given the limited resolution, noncrystallo-
graphic symmetry (NCS) restraints were applied. The core of
the assembly is the previously reported TreS tetramer (Fig. 2A)
(14). In the diamond-shaped TreS tetramer, the -sandwich
domains of the TreS subunits are paired up and constitute the
“top” (chains A and B) and “bottom” apex (chains C and D) of
the diamond (Fig. 2A). In the hetero-octamericTreS:Pep2 com-
plex, pairs of Pep2 monomers straddle across the -sandwich
domains of the TreS tetramer in a clamp-like fashion (Fig. 2B).
We refer to this assembly as the 4 4 complex, whichmeasures
175 Å in its long dimension, 125 Å across, and 90 Å in
depth. Pep2 appears to dimerize on the TreS tetramer, but the
contact surface between the Pep2monomers is small compared
with the contact surfacewithTreS (see Fig. 2C), suggesting they
bind independently as monomeric copies.
The asymmetric unit (ASU) of the crystal lattice contains two
copies of the TreS:Pep2 complex (complexes 1 and 2), which
display differences in terms of subunit orientation and level of
Figure 1. Schematic diagram of the GlgE pathway of mycobacterial
-glucan synthesis. Conversion of trehalose to maltose 1-phosphate pro-
ceeds through isomerization (TreS) and phosphorylation (Pep2) of the disac-
charide (generated using ChemBioDraw).
Figure 2. Architecture of theM. smegmatis TreS:Pep2 complex.A, viewof
the TreS tetramer, illustrating juxtaposition of the C-terminal -sandwich
domains (hues ofmagenta) at the apices of the tetramer. The tetramer shown
is from the first of two complex copies in the asymmetric unit (complex 1)
with chain identifiers A–D. B, assembly of the TreS:Pep2 complex in the orien-
tation of A, with TreS and Pep2 subunits shown in blue and green ribbons,
respectively. Spheres indicate the location of the active sites, as derived from
the superposition with substrate-bound homologous structures. Capital let-
ters designate the chain identifiers in complex 1. C, top view of the assembly
shown in B, with Pep2 subunits rendered as molecular surfaces. The rotation
relative to B is indicated. D, illustration of the relative spatial positions of the
active sites of TreS andPep2. The line inmagenta shows the lineardistance (53
Å) between the disaccharide-binding sites, and the openings of the actives
sites to solvent are marked.
Crystal structure of the TreS:Pep2 complex
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disorder. For instance, when superimposing the TreS tetramers
of complexes 1 (chains A–D) and 2 (chains E–H) onto the
structure of stand-alone M. smegmatis TreS (PDB code 3ZO9
(19)), the average displacement (RMSD) of C atoms is very
small for complex 1 (0.45 Å for 2243 aligned C atoms) but
considerably larger for complex 2 (RMSDof 3.4 Å, 2175 aligned
C atoms). The origins of this mismatch are rotations of the
TreS protomers relative to each other, evident by altered
gaps between the subunits’ molecular surfaces when ori-
ented according the alignment described above and by
changes of the distances between the substrate-binding sites
of up to about 6 Å (Fig. S1).
The backbone of Pep2 shows various levels of disorder across
the eight protomers in the ASU. In complex 1 (Pep2 chains I–L,
Fig. 2B), the backbone of Pep2 could be traced over 436 of the
441 residues for three subunits (chains I, J, and L), but residues
1–86 are largely disordered in the fourth subunit (chain K). In
complex 2 (Pep2 chainsM–P), only one copy of Pep2 (chainM)
could be traced fully, whereas residues 1–194 were disordered
in chains N, O, and P.
Structure of Pep2
The structural model of Msm Pep2 in the present complex
structure is completely defined by electron density bar two res-
idues of the N-terminal sequence and 4–5 residues at the C
terminus. Despite themoderate resolution, the density displays
sufficient detail to dock the Pep2 amino acid sequence onto the
backbone structure, aided in part by the recent structures of
M. tuberculosis (Mtb) and Mycobacterium vanbaalenii (Mvb)
Pep2 (20, 21) (Fig. S2). However, side chains were omitted from
the model, where corresponding density was missing.
The Pep2 structure shows the prototypical two-lobe archi-
tecture of phosphotransferase enzymes of PFAM family
PF01636. Characteristic for this family and that of protein
kinase domains (PFAM family PF00069) is the -helical C-ter-
minal lobe (Fig. 3A). This is illustrated by comparison with the
closest nonmycobacterial structural neighbor, Bacillus subtilis
methylribose kinase (PDB code 2PUL (22), RMSD 3.9 Å, 262
aligned C, Fig. 3B), which superimposes with the C-terminal
lobe and parts of theN-terminal lobe of Pep2.However, in Pep2
the N-terminal lobe includes a novel -sheet at the N terminus
(1–3), which appears to be unique for mycobacterial Pep2
enzymes, and is missing in structural neighbors identified by
distance matrix alignment (DALI (23)), including methylribose
kinase. In contrast, the seven-stranded -sheet preceding the
C-terminal lobe (6–12) is conserved.We refer to the latter as
the canonical -sheet, although it includes two additional non-
conserved strands (6 and 7) at its N terminus (Fig. 3C).
The unique three-stranded -sheet, which is preceded by a
two-turn -helix, is visible in only a subset of Pep2 protomers
(Fig. 3, A and C), with density lacking between the N terminus
and helix 3 (corresponding to residues 1–88) in four of eight
Pep2 protomers. Superimposing the Pep2 copies (chains I, J, L,
and M), which could be fully traced, with respect to residues
198–400 of the C-terminal lobe results in a close match for the
canonical -sheet of the N-terminal lobe, but it reveals consid-
erable conformational flexibility for the unique -sheet with a
rotation of 28° between the two extreme conformers about
the “hinge residue” Leu-86 (Fig. 3D). Furthermore, we note that
the domain swap seen in the structure ofMtbPep2 (21) involves
strands of the canonical -sheet (Fig. 3E).
The functional role of the unique -sheet in Pep2 is not
immediately evident from the structure. The nucleotide-bind-
ing site resides in the N-terminal lobe, whereas maltose binds
opposite to the nucleotide in a pocket of the C-terminal lobe
(Fig. 3A) (21). Superimposing Pep2 with the ATP-bound struc-
ture ofMvb Pep2 (PDB code 4WZY (20)) suggests that residues
in the unique region of the N-terminal lobe do not directly
contact the nucleotide, but onemight expect that perturbations
of this part of the structure affect nucleotide binding and poten-
tially activity (see “Discussion”).
Location of active sites
Given that TreS and Pep2 catalyze consecutive reaction steps
in the GlgE pathway, it has been suggested that products of the
Figure 3. Structure of M. smegmatis Pep2 and topology of its N-terminal
lobe. A, ribbon diagram of theM. smegmatis Pep2 (MsPep2)monomer. The con-
served and unique regions in the N-terminal lobe are shown in hues of blue,
matching thecolor schemeof the topologydiagram inC.Spheres ingray indicate
thebindingsitesofnucleotideandmaltose,asderivedfromsecondarystructure-
matched superposition with GDP-bound aminoglycoside 2-phosphotrans-
ferase IIIa (PDB code 3TDW (38)) and maltose-bound M. tuberculosis Pep2 (PDB
code 4O7P (21)), respectively. B, ribbon diagramof B. subtilismethylribose kinase
(PDB code 2PUL (22)), the closest structural neighbor of Pep2 according to DALI
(23) (RMSD3.9Å for262alignedCpositions, 12% identity).C, topologydiagram
of theN-terminal lobeofMsPep2.D, superpositionofMsPep2 chains I, J, L, andM
with respect to residues 198–400. E, superposition ofMsPep2withM. tuberculo-
sis Pep2 (MtPep2) (PDB code 4O7O (21), gray ribbon). Secondary structure labels
referring toMtPep2areprecededby theprefixMtb. TheC tracesdeviate follow-
ing strand 7, where the backbone ofMsPep2 (magenta) traverses to the other
end of the canonical -sheet (8), whereas the backbone of MtPep2 (yellow)
extends to the adjacent, NCS-related copy of Pep2 in a domain swap-mediated
dimerization.
Crystal structure of the TreS:Pep2 complex
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TreS-catalyzed reactionmay be channeled directly to the active
site of Pep2 (21).However, no such path or channel between the
active sites of TreS and Pep2 is apparent in the complex struc-
ture. The linear distance from the active site of TreS (chain A)
to the nearest maltose-binding site of Pep2 (chain J) measures
about 53 Å and traverses the C-terminal lobe of Pep2 (Fig. 2D
and Fig. S3). The next nearest maltose-binding site (chain I) is
63Å away, and this time the direct line crosses the hydrophobic
core of TreS, again without an obvious opening or tunnel.
Within the complex, the active sites of TreS and Pep2 are both
open to solvent and do not face each other (Fig. 2D), suggesting
that following release from TreS, maltose needs to diffuse
through solvent on the way to the active site of Pep2.
TreS:Pep2-binding interface
Pep2 forms intimate contacts with the TreS tetramer, reveal-
ing a high level of shape complementarity between the binding
partners (Fig. 4A). Complex formation buries about 1200 Å2 of
solvent-accessible surface permonomer. The footprint of a sin-
gle Pep2 subunit covers surface areas belonging to two TreS
protomers, including and extending beyond the C-terminal
-sandwich domain(s) (Fig. 4B). Both lobes of Pep2 contribute
to the contact surface, but the C-terminal lobe provides the lion
share (Fig. 4C and Fig. S2). Where parts of the N-terminal lobe
are disordered, the C-terminal lobe accounts for all observed
contacts. Secondary structure elements contributing to the
binding interface are helices 5, 6, and 10 in the C-terminal
lobe of Pep2, and contactsmade by theN-terminal lobe include
residues in helix 2, in strand 8, and in the 9–10 loop (Fig.
4C). In addition, contacts also involve the 12–5 loop, which
links the N- and C-terminal lobes. The binding interface is
dominated by van der Waals and hydrophobic contacts, corre-
sponding to 70% of surface area buried in the interface per
Pep2 monomer. In addition, eight hydrogen bonds and two salt
bridges (TreS–Arg-312:Pep2–Asp-228 andTreS–Arg-534:Pep2–
Asp-218) complement the noncovalent interactions (Table S2).
The binding interface shares structural elements with the
nucleotide-binding site, based on the superposition with the
ATP-bound structure ofMvbPep2 (PDB code 4WZY (20)) (Fig.
S3). According to this superposition, we predict several resi-
dues to make contacts with ATP that are part of (or right next
to) the binding interface with TreS. Residues in the maltose-
binding site (derived from the superposition with maltose-
bound Mtb Pep2 (PDB code 4O7P (21)) make no direct con-
tacts with TreS.
Stoichiometry and affinity of theM. smegmatis TreS:Pep2
complex in solution
We had previously investigated the stoichiometry of the
complex formed by theM. tuberculosis orthologues and found,
by analytical ultracentrifugation in equilibrium mode, that the
complex encompasses 4  4 subunits (Mr 490,000) (14).
However, purifiedMtb Pep2 eluted from a size-exclusion resin
as a mix of species (monomers, dimers, and higher oligomers)
(14), in contrast to the essentially single-peak elution of mono-
meric Msm Pep2 (Fig. S4). We therefore wished to ascertain
whether the self-association behavior affected complexation
with TreS.
We initially probed the assembly of the Msm TreS:Pep2
complex by size-exclusion chromatography. As was ob-
served previously for the M. tuberculosis orthologues, addi-
tion of Pep2 to TreS leads to a shift of the TreS tetramer peak
to shorter retention times, suggesting complex formation
(Fig. S4). We also noticed that the association of Msm TreS
and Pep2 was pH-dependent. Between pH 7 and 8, the posi-
tion of the complex peak moved to longer retention times,
whereas the absorbance signal corresponding to the Pep2
monomer increased (Fig. S4). In accordance with the stron-
ger association between TreS and Pep2 at mildly acidic pH,
the best diffracting crystals were obtained at reservoir pH
values between 6.7 and 7.0.
To determine the affinity between Msm TreS and Pep2, we
measured binding by isothermal titration calorimetry (ITC),
buffering with phosphate, and titrating Pep2 to TreS up to a
Figure 4. Contact surfaces between TreS and Pep2. A, side view of the
TreS:Pep2 interface for chain I of MsPep2. The surface of TreS is colored gray
and in hues of magenta (indicating the C-terminal -sandwich domain of
TreS). MsPep2 is colored in hues of blue (N-terminal lobe) and orange (C-ter-
minal lobe). Contact surfaces between TreS and Pep2 are colored green (on
TreS) and yellow (on Pep2) according to burial of solvent-exposed surface
(calculated using PISA (39)). B, area (green) on the molecular surface of TreS
contacted by chain I ofMsPep2 as seen from the position of the Pep2 subunit.
The dashed line indicates the boundary between the C-terminal -sandwich
and the TIM-barrel domains of TreS. C, area on Pep2 (chain I) contacted by
TreS, as seen from the viewpoint of the latter. Areas in yellow and green con-
tact TreS chains B and A, respectively.
Crystal structure of the TreS:Pep2 complex
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molar ratio [Pep2]/[TreS] of about 1.5. Setting the initial con-
centration of TreS at 75 M, wemeasured binding isotherms at
25 °C at pH 6.5, 7.5, and 8.5 (Table 1 and Fig. 5A). Fitting a
single-site binding model, the strongest affinity was measured
at pH 6.5 with a Kd of 3.5 M, increasing to 34.8 M at pH 8.5
(Table 1). In terms of standardGibbs energy,G0, the change is
about 16%. Importantly, the ITC data also allow one to derive
the stoichiometry of the interaction, n, which was about 0.5 for
pH 6.5 and 7.5 (Table 1). As Pep2 was titrated to TreS, which
forms a stable tetramer in solution (14), a value ofn 0.5means
that the TreS tetramer binds two copies of Pep2. As the affinity
decreased with rising pH, n dropped to 0.22, suggesting a single
copy of Pep2 is binding to the TreS tetramer at pH 8.5. Finally,
we tested whether the binding affinity was sensitive to the ionic
strength of the buffer, and we found that theKd value remained
unchanged between 200 and 400 mM NaCl (Table S3).
We corroborated the apparent 2:1 stoichiometry of theMsm
TreS:Pep2 complex by analytical ultracentrifugation in sedi-
Figure 5. Probing binding betweenM. smegmatis TreS and Pep2 by isothermal titration calorimetry and sedimentation equilibrium analysis of the
M. smegmatis TreS:Pep2 complex. A and B, proteins were in sodium phosphate buffer at pH values of 6.5, 7.5, and 8.5. The starting concentration of TreS in
the reaction chamber was 75M, and Pep2was titrated up to nominal molar ratio of1.5. A, trace of the injections at pH 6.5 and plot of integrated peak areas
versus concentration ratio [Pep2]/[TreS], with the fit representing a single-site binding model. B, fit of a two-site binding model to the data in A. C, 1:1 molar
mixture ofM. smegmatis TreS andPep2was analyzed at threedifferent protein concentrations ([TreS]3.75, 2.5, and1.25M) and three rotation speeds (8000,
9000, and 10,000 rpm). Data points are shown as open symbols, and solid lines represent the best fit (top panel) and residuals (lower panel), respectively. The
fittedmasswas372,823Da, comparedwitha calculatedmassof 370,407Da for a complexof 4TreS2Pep2.Data shown illustrate the fit for thehighestprotein
concentration (see also Fig. S5).
Table 1
ITC data of the TreS:Pep2 interaction
The sample chamber contained 75 M M. smegmatis TreS at the start of the titration, and Pep2 or Pep2-70 was titrated to TreS up to a molar ratio of about 1.5 of
Pep2/TreS.
Pep2 (wildtype) Pep2-70
pH 6.5 7.5 8.5 6.5
T (K) 298 298 298 298
Single-site binding model
Ka (105 M	1) 2.87
 0.26 1.60
 0.12 0.287
 0.03 0.35
 0.08
Kd (M) 3.48 6.25 34.8 26.8
G0 (kJ/mol) 	31.1 	29.7 	25.4 	25.9
H0 (J/mol) 	131,000 	78,400 	93,200 	74,900
TS0 (J/mol) 	99,400 	48,700 	67,600 	49,000
n 0.574
 0.007 0.459
 0.008 0.22
 0.04 0.681
 0.004
Two-site binding model
Ka, 1 (105 M	1) 19.7
 3.2
Ka, 2 (105 M	1) 0.55
 0.08
Kd, 1 and Kd, 2 (M) 0.5, 18
n1 and n2 0.445
 0.004, 0.457
 0.055
Crystal structure of the TreS:Pep2 complex
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mentation equilibrium mode, comparing the sedimentation of
theMsmTreS tetramer to an equimolar molar mixture ofMsm
TreS and Pep2. Fitting a single-speciesmodel against data from
three protein concentrations (6, 4, and 2M) and three different
rotor speeds (Fig. 5C and Fig. S5), themass determined forMsm
TreSwas 248,550Da, comparedwith the calculatedmass of the
MsmTreS tetramer of 272,000 Da. A 1:1molarmixture of TreS
and Pep2 (3.75, 2.5, and 1.25 M with respect to monomers)
analyzed in the sameway resulted in a fittedmass of 372,823Da.
Given calculated masses of 272,000 Da for the TreS tetramer
and 48,800 Da for the Msm Pep2 monomer, and considering
that Msm Pep2 elutes predominantly as a monomeric species
from the size-exclusion resin (Fig. S4), the data strongly suggest
that the sedimenting complex is the TreS tetramer binding two
copies of Pep2, which is a “4 2” complex.
Enzymatic activity of Msm Pep2
We had observed previously that activity of Mtb Pep2
increasedmarkedly in the presence ofMtbTreS (14).We tested
whether this was also the case forMsm Pep2. Given the pH-de-
pendent affinity between Msm Pep2 and TreS, we first tested
how activity responds to pH, and we found that it declined
significantly as pH decreased (Fig. 6A and Table 2). Yet even at
the lowest pH, Msm Pep2 activity was still several orders of
magnitude higher than that ofMtb Pep2 in terms ofVmax at the
same assay conditions (Vmax corrected for enzyme concentra-
tion, cf. Table 2 in Roy et al. (14)). At pH 6.0,Msm Pep2 activity
was largely indifferent to addingMsmTreS when varyingmalt-
ose (ATP at 0.3 mM, Fig. 6B). In the converse experiment, add-
ingMsm TreS at molar ratios of 1:1 or 4:1 (TreS:Pep2) toMsm
Pep2 slightly depressed activity at pH 7.5 but had virtually no
effect at pH 6.0 (Fig. 6, C and D). Thus, the rate enhancement
effect observed for the Msm TreS:Pep2 complex does not
appear to hold for theM. smegmatis orthologues, although the
latter is more active than the former by several orders of
magnitude.
Is theM. smegmatis complex structure representative of Mtb
TreS:Pep2?
The discrepancy between the TreS:Pep2 complexes of
M. smegmatis andM. tuberculosis in terms of solution stoichi-
ometry and enzymatic behavior upon complex formation
prompted the question whether the present crystal structure is
representative of the TreS:Pep2 complex of M. tuberculosis.
Examining the binding interface, we found that the two salt
bridges (TreS–Arg-312:Pep2–Asp-228 and TreS–Arg-534:
Pep2–Asp-218) link residues that are conserved on either side
of the interface. In addition, a conserved proline residue inTreS
(Pro-503), located in the loop between strands 16 and 17, is
packing tightly against backbone atoms of helix5 of Pep2 (Fig.
7A). We reasoned that introducing a bulky side chain at the
Pro-503 site or swapping the basic side chains (Arg-312 and
Arg-534) for acidic amino acids should be sufficient to destabi-
lize complex formation, given the moderate overall affinity
(Kd 3.5 M). AlthoughMtb TreS–R536E (MsmArg-534) did
not express well enough, sufficient amounts of protein could be
made of Mtb TreS–P511W (Msm Pro-503) and TreS–R320E
Figure 6. Activity ofM. smegmatis Pep2 as a function of pH and in pres-
ence/absence of M. smegmatis TreS. Activity of Pep2 was analyzed, cou-
pling generation of ADP to depletion of NADH (see under “Experimental pro-
cedures”). A, pH dependence of activity in the presence of 20 mM maltose. B,
Pep2 activity at pH 6.0 as a function of maltose concentration (0.3 mM ATP)
and adding TreS at molar ratios as indicated. C and D, probing the effect of
M. smegmatis TreS on Pep2 activity at pH 7.5 and 6.0, respectively, with malt-
ose at 20mM. Data in A–Dwere fitted to theMichaelis-Menten equation (vi
Vmax [S]/(KM [S])). Error bars are omittedwhere they appear smaller than the
corresponding data point marker.
Table 2
Enzymatic activity ofM. smegmatis Pep2
Activity was probed through a coupled assay, spectroscopically monitoring NADH
depletion (see “Experimental Procedures”). Maltose was at 20 mM when titrating
ATP, and ATP was at 0.3 mM when titrating maltose.
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(MsmArg-312). The mutant proteins showed the same elution
behavior on a Superdex 200 size-exclusion resin as WT Mtb
TreS (Fig. 7B, peaks at 10.2 and 11.7 ml), whereby the peak at
11.7 ml likely represents the TreS tetramer (280 kDa) as it is
located between the ferritin marker (440 kDa) and the dimer
peak for albumin (132 kDa). Thus, this comparison indicates
that themutant TreS proteinsmaintain the tertiary structure of
the WT enzyme.
To probe Pep2 binding, we incubated Mtb TreS (WT and
mutants) with an equimolar amount ofMtb Pep2 and analyzed
the protein mixture by size-exclusion chromatography (Fig. 7,
C,D, and E). Only when incubated withWTMtb TreS didMtb
Pep2 drive a distinct shift of the main TreS elution peak at 11.8
ml (Fig. 7C) to 11.4 ml, coinciding with the 440-kDa ferritin
marker. This peak contains both proteins (Fig. S6). In contrast,
incubationwith eithermutant (P511WandR320E, Fig. 7,D and
E) resulted only in aminor shift of the TreS tetramer peak (11.7
ml). The peak representing the Pep2 monomer (15.5 ml) is
eliminated in the incubation with WT TreS (Fig. 7C), but it is
rather prominent when Pep2 is incubated with either mutant
(Fig. 7,D andE). This differential behavior clearly indicates that
Pep2 binding to themutant TreS proteins is perturbed by intro-
Figure 7. ProbingM. tuberculosis TreS:Pep2 complex formation with amino acid substitutions at the binding interface. A, location of the substitution
sitesMsm Pro-303 (Mtb Pro-311) andMsm Arg-312 (Mtb Arg-320), with a close-up view on the right. Pep2 is shown with a translucent molecular surface (blue
and orange ribbon), and TreS is shown as a ribbon only (gray and purple). Residue numbers refer to the Msm sequences, with corresponding Mtb residue
numbers inparentheses. Selected secondary structure elements are labeled,with letters T andP indicatingTreS andPep2, respectively.B, size-exclusionprofiles
of Mtb TreS (WT, P511W, and R320E) and of Mtb Pep2 in the absence of their complex partners. Void volume and position of markers ferritin (11.4 ml) and
albumin (14.8 ml, 13 ml) are indicated. C–E, size-exclusion profiles of Mtb TreS (WT, P511W, and R320E) in the presence of an equimolar amount of Mtb Pep2
superimposed over the elution traces of free TreS of B. For the ease of comparing separate runs, the absorbance signals were scaled such that the maximal
absorbance is indicatedas 1.0. To facilitate adirect comparisonbetween theelutionbehavior of TreS:Pep2 complex (orange) to that of the constituentproteins,
the elution traces of Pep2 (gray) and of the relevant forms of TreS (WT or mutant) of B appear again in C–E (blue).
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ducing mutations at the TreS:Pep2 interface, thus providing
evidence that the Msm TreS:Pep2 complex structure is repre-
sentative of its counterpart inM. tuberculosis.
Discussion
Noncovalent complexes between enzymes that catalyze suc-
cessive reaction steps in metabolic pathways provide a means
for cells to regulate synthesis of metabolites and to efficiently
exploit limited nutritional resources (24). This aspect is espe-
cially relevant for M. tuberculosis, an organism that, for the
most part, resides sequestered in host macrophages, where it
faces a generally nutrient-poor and in particular a carbohy-
drate-poor environment (25). Although the -glucan capsule is
shed readily in culture, previous evidence has implicated-glu-
can synthesis in the ability of M. tuberculosis to persist in the
host (4, 6), and thus regulatory features of pathways linked to
capsule synthesis are likely pertinent for the environmental
niche occupied byM. tuberculosis.
Complex formation between TreS and Pep2 is mirrored by
TreS:Pep2 fusion enzymes in a sizeable subset of microbial spe-
cies (96 bacterial and 6 archaeal as listed in Ref. 9). The TreS:
Pep2 complex structure is compatible with a fused protein in
that the stoichiometry in the crystallized complex is 1:1 and the
C-terminal -sandwich domain of TreS is the docking site for
Pep2. The linear distance between the C terminus of TreS and
the nearest ordered N-terminal residue of Pep2 is 40 Å, a
distance compatible with sequence insertion in TreS:Pep2
fusion from Pseudomonas aeruginosa, which comprises an
additional 16 or 30 residues between the termini of TreS and
Pep2 relative to the M. tuberculosis and M. smegmatis ortho-
logues, respectively (Fig. S7).
The architecture and biochemical behavior of the TreS:Pep2
complex has parallels to the complex of the mycobacterial cho-
rismate mutase (CM) bound to 3-deoxy-D-arabino-heptu-
losonate-7-phosphate synthase (DAHP synthase) of the shiki-
mate pathway of aromatic amino acid biosynthesis (PDB code
2W19 (26)). As is the case for TreS, the catalytic domain of
DAHP synthase folds as an /- or TIM-barrel and exists as a
tetramer in solution. In the hetero-octameric DAHP syn-
thase:CM complex, pairs of CM attach to opposite corners of
the DAHP synthase tetramer (Fig. S8). Importantly, association
of CM with DAHP synthase results in strongly-amplified
mutase activity (26, 27). Rate amplification of mutase activity
was attributed to a re-arrangement of active-site residues upon
CMbinding toDAHP synthase, leading to amolecular environ-
ment favoring catalysis (26).
For TreS:Pep2, the level of rate enhancement is modest in
M. tuberculosis (cf. Table 2 in Ref. 14) and is essentially absent
inM. smegmatis, at least under in vitro conditions (Fig. 6,C and
D, and Table 2). Given that the individual proteins align with
high levels of sequence identity (83% TreS and 66% Pep2), and
given the diminished or abrogated binding of Pep2 when the
Mtb TreS:Pep2 interface is perturbed (Fig. 7), it is unlikely that
complexes from M. tuberculosis and M. smegmatis differ in
architecture, even though the domain-swapped dimeric struc-
ture ofM. tuberculosis Pep2 (21), possibly a crystallization arti-
fact, confounds the comparison. The domain-swapped Mtb
Pep2 dimer is incompatible with the 4 4 architecture, as sig-
nificant steric overlap occurs when superimposing a protomer
of theMtb Pep2 dimer onto, for instance, chain I of Pep2 in the
Msm TreS:Pep2 complex (Fig. S9). Domain swapping is not
seen in the stand-alone structure ofMvb Pep2 (20) (61% iden-
tity toMtb Pep2) nor is it occurring inMsm Pep2 in the context
of the Msm TreS:Pep2 complex. Also, the size-exclusion data
clearly show a mixed population of Mtb Pep2 in solution that
clearly includes a monomeric species (Fig. 7B). Finally, we lack
structures of stand-aloneMsm Pep2 and of theMtb TreS:Pep2
complex.
Notwithstanding the caveats outlined above, the present
complex structure gives hints as to how complex formation
could affect reaction rates. First, four of the eight Pep2 mole-
cules present in the asymmetric unit display a partially disor-
dered N-terminal lobe, which accommodates the ATP-binding
site. This observation suggests inherent structural flexibility of
this region, possibly affecting activity. Indeed, a 70-amino acid
N-terminal truncation (MsmPep2-70, Fig. S10) demonstrates
substantially reduced maltokinase activity and affinity to TreS.
In size-exclusion chromatography, Pep2-70 showed a dimin-
ished shift of the complex peak to shorter retention times,
whereas the dissociation constant, Kd, increased from 3.5 to
28.6 M (Table 1). Notably, the 70-truncation reduced Vmax
10-fold, from 2513 (
 205) to 242 (
 41) mol min	1 mg	1
(Fig. S10).
Second, the complex structure demonstrates that the ATP-
binding site shares structural elements with the TreS:Pep2
interface (Fig. 4C and Fig. S3). Identifying residues involved in
ATP binding by mapping the structure of ATP-bound Mvb
Pep2 (PDB code 4WZY (20)) onto Pep2 (chain I) of the TreS:
Pep2 complex demonstrates a high level of sequence conserva-
tion for residues within a 4 Å distance cutoff of ATP (Fig. S2),
and it identifies secondary structure elements that are part of
the TreS:Pep2 interface and, at the same time, contributes res-
idues to the ATP-binding site. These include the 8–9 loop,
the 12–5 loop, which links N- and C-terminal lobe, and
strand15 (Fig. S3). In contrast, themaltose-binding site, iden-
tified by alignment with maltose-bound Mtb Pep2 (PDB code
4O7P (21)) is completely conserved for contact residues within
a 4 Å distance cutoff (Figs. S2 and S3). Furthermore, the malt-
ose-binding site includes far fewer structural elements sharing
in the TreS:Pep2 interface and contributing contacts to malt-
ose. Thus, wemay attribute the modest rate enhancement seen
in theM. tuberculosisTreS:Pep2 complex to stabilization of the
N-terminal lobe of Pep2 when bound to TreS.
We previously provided evidence that complex formation
between TreS and Pep2 occurs in vivo (14). However, the mod-
erate affinity for binding of Pep2 to TreS (Kd 3.5M) suggests
that the TreS:Pep2 complex is only transient rather than con-
stitutive (24). This notion is also consistent with the predomi-
nant stoichiometry of theMsmTreS:Pep2 complex in the solu-
tion state (TreS4:Pep22). Furthermore, it suggests that even as a
fusion protein, noncovalent association between the TreS and
Pep2 domains may not be constitutive. Such behavior would
resemble endoglucanase EngD fromClostridium cellulovorans,
where the crystal structure shows noncovalent, intramolecular
association between the C-terminal carbohydrate-binding do-
mains and the catalytic domains, but small-angle x-ray scatter-
Crystal structure of the TreS:Pep2 complex
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ing analysis demonstrated that the carbohydrate-binding
domains do not constitutively associate with the catalytic
domains in the solution state (28).
The discrepancy in complex stoichiometry between the crys-
tallized complex and the behavior in solution is likely explained
by crystal lattice contacts, which can influence the thermody-
namic equilibrium by (partial) exclusion of solvent and intro-
duction of packing interactions that do not exist in the solution
state. Close inspection of the ITCdata showed systematic albeit
subtle deviations between the single-site bindingmodel and the
data points (Fig. 5A). Introducing a two-site binding model
removes the systematic deviation (Fig. 5B) and suggests that the
two sites bindwithKd values of 0.5M (site 1) and 18M (site 2),
respectively (Table 1). The stoichiometry for site 1 remains near
0.5 (n1  0.45), whereas for site 2, the stoichiometry is n2 
0.46. Thus, overall the stoichiometric ratios of the two sites add
up to 0.91, i.e. near parity between the complex components,
and the difference in magnitude between Kd, 1 and Kd, 2 could
account for the apparent preponderance of a 4  2 configura-
tion in solution.
Adding parameters to a mathematical model is bound to
result in a more accurate description of the observed data.
However, the crystal structure elegantly rationalizes the bind-
ing behavior observed in the ITC experiment. We propose that
the two distinct binding sites (with different affinities) corre-
spond to binding the first and second copy, respectively, of Pep2
to the same apex of the TreS tetramer (Fig. 8). The binding sites
for pairs of Pep2 monomers at opposite apices of the TreS
tetramer are spatially well separated (Fig. 2, A and B). Thus,
binding of the first copy at one apex (site 1) does not geometri-
cally constrain binding of the first Pep2 copy at the opposite
apex (site 1, Fig. 8), and thus binding to sites 1 and 1 occurs
with the same affinity. However, once an apical position is
occupied by a single copy of Pep2, binding of the second copy
may be hindered by the first copy, and this may lead to an
increase of Kd values for the second binding event. Indeed, the
conformations of the bound Pep2 copies are not identical. By
:Superimposing Pep2 chains I and J, which are fully ordered and
occupy the same apex of the TreS tetramer (Fig. 2B), it emerges
that their N-terminal lobes do notmatchwell (Fig. 3D). Forcing
the two adjacent copies into an identical conformation results
in steric hindrance between their N-terminal lobes. When the
N-terminal lobes are truncated (as in Pep2-70), the stoichi-
ometry determined in the ITC experiment converges to n 
0.68, (Table 1), suggesting that the 4  2 configuration is no
longer dominant.
In conclusion, we have provided a detailed structural
model of the complex formed between trehalose synthase
and maltokinase of mycobacteria, with mutagenesis data
indicating that this complex structure is a valid representa-
tive of the Mtb TreS:Pep2 complex. The structure rational-
izes rate enhancement of Pep2 induced by binding of Pep2 to
the TreS tetramer and together with the example of the
DAHP synthase:CM complex points to complex formation
as a mechanism that can contribute to regulating pathway
activity in mycobacteria.
Experimental procedures
Cloning ofM. smegmatis Pep2, TreS
The DNA sequences of TreS (MSMEG_6515) and Pep2
(MSMEG_6514) were cloned from M. smegmatis genomic
DNA by polymerase chain reaction (PCR) using the following
primers: TreS forward, GATCGATCCATATGGAGGAGCA-
CACGCAGGGCAG, and TreS reverse, GATCGATCAAGC-
TTCATTGCTGGCGCTCCCGGTTCTGGATC; and Pep2
forward, GATCGATCCATATGAGTGTCGAATTCGAGG-
ACTGGC, and Pep2 reverse, GATCGATCAAGCTTCACTC-
CAGAAGACGTGCGATGGAG. The PCR products were
ligated into the NdeI and HindIII sites (underlined) of plasmid
vector pET28a (Novagen), and the expressed proteins included
an N-terminal His6-affinity tag.
Cloning ofM. smegmatis Pep2-70
N-terminally truncated Msm Pep2 was cloned from a
pET28a vector containingMSMEG_6514 (M. smegmatis pep2)
using the Phusion High-Fidelity DNA polymerase kit (New
England Biolabs, UK), introducing a STOP codon at the C
terminus. The primers were as follows: 70 forward, GATCC-
ATATGGTCGCCACGATCGGCATCGCCGAC, and 70
Figure 8. Illustration of the two-site binding model for binding of four
copies of Pep2 to the TreS tetramer. Binding of the first copy of Pep2 at an
unoccupied apical binding site (Site 1) is governed by Kd, 1 and does not influ-
ence affinity for binding of the first copy at the opposite apex (Site 1). Hence,
Sites 1 and 1 have identical dissociation constants. Binding of the second
copy of Pep2 may encounter steric constraints imposed by the previously
bound copy, and therefore, the affinity for binding the second copy, Kd, 2, at
Site 2 (or Site 2) is different.
Crystal structure of the TreS:Pep2 complex
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reverse, GATCAAGCTTTCACTCCAGAAGACGTGCGAT-
GGAGCCCAG. The purified PCR product (QIAquick extrac-
tion) was ligated into the NdeI and HindIII restriction sites of
plasmid vector pET28a, yielding a construct encodingN-termi-
nally His6-tagged Pep2-70.
Protein production
Escherichia coli BL21 (DE3) cells were heat-transformed
with plasmids, encoding eitherMsmTreS or Pep2, and cultured
onto agar plates (LB/kanamycin 25g/ml). A single colony was
used to inoculate 10 ml of LB broth and 1% (w/v) glucose and
kanamycin (25 g/ml), incubated overnight (37 °C), and prop-
agated to bulk cultures of Terrific Brothmedia (29) (kanamycin
at 50 g/ml, 37 °C, 180 rpm). At A600  0.4–0.6, the cultures
were cooled to 16 °C (3 h), and protein expression was induced
using 0.6 mM IPTG (TreS) or 0.1 mM IPTG (Pep2) and incu-
bated (12–16 h, 16 °C, 180 rpm). For Pep2 expression, 10 mM
maltose (final concentration) was added to the culturemedium
prior to induction with IPTG. Cells were harvested (7000  g,
10 min, 4 °C), washed with phosphate-buffered saline (PBS),
and resuspended in lysis buffer (30 ml, 25 mM HEPES-NaOH,
pH 7.6, 10% (v/v) glycerol), including either 0.3 M (TreS) or 1 M
(Pep2) NaCl. Pellets were frozen (	80 °C), thawed, and supple-
mented with protease inhibitor mixture (Roche Applied Sci-
ence), 1 mM phenylmethylsulfonyl fluoride, 10 mM MgCl2, and
10g/ml DNase I pellet, as well as maltose (for Pep2 lysate, 100
mM final concentration), followed by passage (four times)
through a French press (Thermo Spectronic FA-078). The
cleared lysate (27,000 g, 30 min, 4 °C) was diluted 4-fold with
buffer A (25 mM HEPES-NaOH, pH 7.6, 10% (v/v) glycerol),
filtered (0.45-m pore size), and loaded on a pre-equilibrated
Ni-NTA column (5 ml, GE Healthcare).
The column matrix was washed with buffer A and with 20,
40, and 60 mM imidazole in buffer A, respectively. The protein
was eluted with 500 mM imidazole in buffer A, and fractions
were analyzed by SDS-PAGE. The eluate was diluted 20-fold
with buffer B (20 mM BisTris, pH 6.0, 10% (v/v) glycerol for
TreS, 50 mMMES, pH 5.8, 10% (v/v) glycerol for Pep2), filtered
(0.45 m), and applied on a HiTrap Q-column (1 ml, GE
Healthcare) pre-equilibrated with 20 mM BisTris, pH 6.0, 50
mM NaCl (for TreS) or 50 mM MES, pH 5.8, 100 mM NaCl (for
Pep2). The column was washed with buffer B supplemented
with NaCl (50–500 mM, increments of 50 mM). Fractions were
analyzed by SDS-PAGE and pooled, followed by concentration
in AmiconUltra-4 centrifugal filter units, and then loaded onto
a HiPrep Sephacryl 26/60 S-300HR column (GE Healthcare).
Fractions containing protein were concentrated as described
before. The purification of Pep2-70 followed the protocol of
WT Pep2, except that NaCl was set to 300 mM prior to ion
exchange chromatography, rather than 50 mM.
Crystallization and structural determination
Crystals of the TreS:Pep2 complex were grown by vapor dif-
fusion in 96-well plates, using a Mosquito liquid handling sys-
tem (TTP Labtech) to set up crystallization drops (100 nl of
protein  100 nl of reservoir solution) containing mixtures of
M. smegmatis TreS and Pep2, at molar ratios between 1:1 and
1:2. Well-formed crystals grew over a reservoir of 9–10% PEG
8000, 4% v/v glycerol, 200 mM MgCl2, and 0.1 M Tris-HCl, pH
6.7–7.0. Crystals were immersed briefly in mother liquor sup-
plemented with 15–20% (v/v) glycerol, and flash-frozen in liq-
uid nitrogen. Diffraction data (Table S1) were processed using
XDS/XSCALE (30). Phases were calculated by molecular
replacement (MR) (PHASER (31)) using PDB code 3ZO9 (19)
as the initial search model.
The first of two copies of the TreS tetramer could be placed
using a tetrameric search model (PDB code 3ZO9, PHASER, Z
score 30 after translation search), whereas the second TreS
tetramer was placed by searching with a single TreS subunit
and then deriving positions of the other three monomers by
applying NCS operators. The individual protomers were
adjusted into clearly visible secondary structure density by real-
space rigid-body fitting (COOT (32)).
An initial model for Pep2 was generated using the HHpred
threading server (https://toolkit.tuebingen.mpg.de/#/tools/
hhpred6 (33)) and theMODELLER software (34), covering res-
idues 100–440 of the Pep2 sequence. A first copy of Pep2 was
placed byMR (PHASER,Z score11), whichmatched second-
ary structure density features that had appeared by phasing
with TreS alone. Further copies of Pep2 were placed in a cyclic
fashion, applying NCS operators, then real space rigid body
fitting, refining the combined model in REFMAC5, and reiter-
ating the cycle. After placing three copies of Pep2, the resulting
A-weighted 2Fo	Fcdensitymapdisplayed additional second-
ary structure elements not covered by the Pep2 model, reveal-
ing the location of helix 3 and strands 1–3, respectively.
Iterative rounds of chain tracing, model rebuilding and refine-
ment (COOT (32), REFMAC5 (35), and PHENIX.REFINE (36))
allowed us to construct amodel comprising twoTreS tetramers
and the backbone of eight Pep2monomers. In the later stages of
building this model, we obtained access to the coordinates of
Pep2 fromM. tuberculosis (PDB code 4O7O (21)) andM. van-
baalenii (PDB code 4U94 (20)), which helped to correct the
sequence register and to dock side chains onto the backbone
structure where justified by density. We applied tight NCS
restraints throughout and modeled atomic displacements by
refining TLS parameters (one set per protomer) and grouped B
factors. Refinement statistics are shown in Table S1. Structure
factors and coordinates for the crystal structure ofM. tubercu-
losis TreS:Pep2 are deposited in the PDB under accession code
5JY7.
Size-exclusion chromatography
The elution of equimolar molar mixtures of TreS:Pep2 from
a Sephacryl S-300HR resin (320-ml column volume) was
assayed at pH 6.0–9.0, monitoring UV absorbance at 280 nm
with a flow rate of 0.5 ml/min, and loading the column with an
initial concentration of 30 M for each protein. The proteins
were buffered in 50 mM sodium phosphate, 300 mM NaCl, 10%
(v/v) glycerol. The pH value was set by choosing appropriate
ratios of mono- to dibasic sodium phosphate. Fractions (5 ml)
were analyzed by SDS-PAGE. For the elution of Pep2-70 from
the same size-exclusion matrix, the protein was in 50 mM MES
6 Please note that the JBC is not responsible for the long-term archiving and
maintenance of this site or any other third party hosted site.
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buffer, pH 6.0, 500 mM NaCl, and 10% (v/v) glycerol. The asso-
ciation of Pep2-70 with TreS was analyzed in 50 mM sodium
phosphate, pH 6.5, 300 mM NaCl, 10% (v/v) glycerol.
Analytical ultracentrifugation
Sedimentation equilibrium was carried out in a Beckman
Optima XL-A analytical ultracentrifuge equipped with absor-
bance optics. Protein sampleswere dialyzed overnight in 50mM
sodium phosphate, pH 6.5, 300 mM NaCl, and 10% (v/v) glyc-
erol. Equilibrium experiment was performed using six-channel
Epon centerpieces with quartz windows at a rotor temperature
of 4 °C for a total duration of 116 h. Absorbance data were
recorded at 280 nm at rotation speeds of 8000, 9000, and
10,000. At each rotation speed, the sample was allowed to reach
equilibrium during a 24-h period. Finally, the sample was run at
25,000 rpm for 20 h. The data were analyzed using SEDPHAT
(37). Parameters for solvent density and viscosity and for the
partial specific volume of the proteins were calculated using
SEDNTERP.
Activity assay
To monitor phosphorylation of maltose, conversion of ATP
to ADP was enzymatically coupled to oxidation of NADH
(via pyruvate kinase and lactate dehydrogenase), and the lat-
ter was monitored fluorometrically (excitation 340 nm and
emission 450 nm). Fluorescence units were converted to
concentrations of ADP by an internal calibration curve for
NADH. The assays were performed in triplicate in 96-well
plates, using a BMG PHERAstar FS microtiter plate reader,
and MARS and GraphPad Prism software to record and ana-
lyze data, respectively.
Reaction mixtures contained 50 mM sodium phosphate, 300
mMNaCl, 10% (v/v) glycerol, 10mMMgCl2, adjusting the pHby
mixing mono- and di-basic buffer in appropriate ratios.
Enzyme concentrations were 0.45-1.0M forWTPep2 or 1-.35
M for the mutant Pep2-70. When varying ATP, maltose was
present at 20 mM, and ATP was at 0.3 mM when varying malt-
ose. The coupling reagents were present at these initial concen-
trations: 4 mM phosphoenolpyruvate, 2 units of pyruvate
kinase, 2 units of lactate dehydrogenase, and 0.1 mM NADH.
ITC experiments were performed using a VP-ITC micro-
calorimeter from MicroCal, LLC (Northampton, MA). Both
proteins, TreS and Pep2, were dialyzed against 50 mM sodium
phosphate, pH 6.5–8.5 (mixing mono- and dibasic phosphate),
300 mM NaCl, and 10% (v/v) glycerol. Prior to the experiment,
the buffered protein solutions were degassed while incubating
at 2 °C below the experimental temperature (25 °C). A total vol-
ume of 288 l of Pep2 (at 500 M in the syringe) was titrated
into 1.4 ml of TreS (75 M initial concentration with respect to
monomer). A total of 29 injections (10l each time)weremade,
with a 300-s interval between injections. The data were ana-
lyzed using the Origin 7.0 software package (Microcal, North-
ampton, MA). The experimental data were fitted to models
describing either one or two binding sites.
Site-directedmutants ofMtbTreSwere generated byde novo
gene synthesis (Genescript), and the resulting DNA sequences
(codon-optimized for expression inE. coli) were subcloned into
pET28a plasmids containing a kanamycin resistance cassette.
Plasmids were verified by sequencing and heat -hock trans-
formed into E. coli BL21(DE3) cells, and transformants were
cultured on LB agar plates selecting for kanamycin resistance
(50g/ml kanamycin, 37 °C, overnight). Proteins were purified
from cell extracts as described under “Protein production,” but
replacing the ion-exchange with a size-exclusion column
(Superdex 200 Increase 10/300 GL, GE Healthcare). Fractions
of the Ni-NTA eluates containing the His-tagged proteins were
pooled, concentrated to a volume of1ml (AmiconUltra,10
kDa), and applied to the Superdex column, which was pre-
equilibrated in 50 mM NaPO4, pH 6.5, 100 mM NaCl, and 10%
v/v glycerol, with buffer exchange occurring through the size-
exclusion step.
Complex formation betweenMtb Pep2 andMtb TreS (WT,
or mutants P511W and R320E) was probed by size-exclusion
chromatography (Superdex 200 Increase 10/300 GL, bed vol-
ume 24 ml) and monitoring UV absorbance at 280 nm. Prior to
loading the column, equimolar amounts ofMtb Pep2 andMtb
TreS (WTormutants) weremixed, incubated on ice for 30min,
then loaded onto the column, and eluted with a flow rate of 0.5
ml/min for a total elution volume of 30 ml. Elutions from the
column were calibrated using bovine albumin (66 kDa) and
ferritin (440 kDa).
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